Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021
by from Morbidity and Mortality Weekly Report (MMWR) on (#5TGDT)
This report describes interim estimate of vaccine effectiveness among adolescents who received the COVID-19 Pfizer-BioNTech vaccine.